Increased Survival after Treatments with Anticancer Agents of Chinese Hamster Cells Expressing the Human Mr 27,000 Heat Shock Protein

Cancer Research

Volumn 51, Issue 19, 1991, Pages 5245-5252

  Huot, Jacques ^a   Roy, Gaetan ^a   Lambert, Herman ^a   Chretien, Pierre ^a   Landry, Jacques ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; COLCHICINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; HEAT SHOCK PROTEIN; HYDROGEN PEROXIDE; NITROSOUREA DERIVATIVE; VINCRISTINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL LINE; CLONE; DRUG SENSITIVITY; HAMSTER; HEAT TOLERANCE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMAL; ANTINEOPLASTIC AGENTS; ARSENIC; BLOTTING, WESTERN; CARMUSTINE; CELL LINE; CELL SURVIVAL; COLCHICINE; DACTINOMYCIN; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE; ETOPOSIDE; FLUOROURACIL; HAMSTERS; HEAT-SHOCK PROTEINS; HUMAN; HYDROGEN PEROXIDE; PENTOSYLTRANSFERASES; SUPPORT, NON-U.S. GOV'T; TENIPOSIDE; VINCRISTINE;

EID: 0025988318     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Henderson, J. F., and Brockman, R. W. Biochemical mechanisms of drug resistance in cancer chemotherapy. In: Pharmacological basis of cancer chemotherapy, M. D. Anderson Symposium, pp. 629-642. Baltimore: Williams & Wilkins Co., 1975.
2. Moscow, J. A., and Cowan, K. H. Multidrug resistance. J. Natl. Cancer Inst., 80: 14-20, 1988.
3. Tsuruo, T. Mechanisms of multidrug resistance and implications for therapy. Jpn. J. Cancer Res., 79:285-296, 1988.
4. Gottesman, M. M., and Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem., 263:1263-1266,1988.
5. Kartner, N., Riordan, J. R., and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Washington DC), 221: 1285-1288, 1983.
6. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171,1989.
7. Gros, P., Ben Neriah, Y. B., Croop, J. M., and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 323:728-731,1986.
8. Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., and Pastan, I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA, 83:4538-4542, 1986.
9. Ling, V., Kartner, N., Sudo, T., Siminovitch, L., and Riordan, J. R. Multi-drug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat. Rep., 67:869-874,1983.
10. Peterson, R. H. F., Meyers, M. B., Spingler, B. A., and Biedler, J. H. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine. Cancer Res., 43:222-228, 1983.
11. Bell, D. R., Gerlach, J. H., Kartner, N., Buick, R. N., and Ling, V. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J. Clin. Oncol., 3:311-315, 1985.
12. Bourhis, J., Goldstein, L. J., Riou, G., Pastan, I., Gottesman, M. M., and Benard, J. Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res., 49: 5062-5065,1989.
13. Rutledge, M. L., Robey-CafTerty, S. S., Silva, E. G., and Bruner, J. M. Monoclonal antibody C219 detection of multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma. Mod. Pathol., 3:298-301, 1990.
14. Kartner, N., Shales, M., Riordan, J. R., and Ling, V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res., 43:4413-4419, 1983.
15. McGrath, T., Marquardt, D., and Center, M. S. Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM. Biochem. Pharmacol., 38:497-501,1989.
16. Glisson, B. S., Gupta, R., and Hodges, P. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res., 46: 1939-1942, 1986.
17. Per, S. R., Mattern, M. R., Mirabelli, C. K., Drake, F. H., Johnson, R. K., and Crooke, S. T. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function. Mol. Pharmacol., 32: 17-25,1987.
18. Pommier, Y., Kerrigan, D., and Kohn, K. W. Topoisomerase alterations associated with drug resistance in a line of Chinese hamster cells. NCI (Natl. Cancer Inst.) Monogr., 83-87,1987.
19. Charcosset, J. Y., Saucier, J. M., and Jacquemin-Sablon, A. Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyel-lipticine resistant cells. Biochem. Pharmacol., 37:2145-2149,1988.
20. Kramer, R. A., Zakher, J., and Kim, G. Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science (Washington DC), 241: 694-697, 1988.
21. Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M., and Tew, K. Glutathione-S-transferase x as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 265:4296-4301,1990.
22. Moscow, J. A., Townsend, A. J., and Cowan, K. H. Elevation of r class glutathione 5-transferase activity in human breast cancer cells by transfection of the GST r gene and its effect on sensitivity to toxins. Mol. Pharmacol., 36: 22-28, 1989.
23. Beck, W. T. The cell biology of multiple drug resistance. Biochem. Pharmacol., 36:2879-2887,1987.
24. Croop, J. M., Gros, P., and Housman, D. E. Genetics of multidrug resistance. J. Clin. Invest., 81:1303-1309,1988.
25. Landry, J., Bernier, D., Chretien, P., Nicole, L. M., Tanguay, R. M., and Marceau, N. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. Cancer Res., 42:2457-2461, 1982.
26. Spitz, D. R., Dewey, W. C., and Li, G. C. Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in Chinese hamster fibroblasts. J. Cell. Physiol., 131: 364-373, 1987.
27. Lee, K. J., and Hahn, G. M. Abnormal proteins as the trigger for the induction of stress responses: heat, diamide, and sodium arsenite. J. Cell. Physiol., 136: 411-420,1988.
28. Li, G. C., and Hahn, G. M. Ethanol-induced tolerance to heat and to adriamycin. Nature (Lond.), 274:699-700, 1978.
29. Landry, J., Lamarche, S., and Chretien, P. Heat shock protein: a lead to the understanding of cell thermotolerance. In: K. Henle (ed.), Thermotolerance, Vol. 1, pp. 145-174. Boca Raton, FL: CRC Press, 1987.
30. Chin, K-V., Tanaka, S., Darlington, G., Pastan, I., and Gottesman, M. M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem., 265: 221-226, 1990.
31. Li, G. C. Heat shock proteins: role in thermotolerance, drug resistance, and relationship to DNA topoisomerases. NCI (Natl. Cancer Inst.) Monogr., 4: 99-103, 1987.
32. Rowe, T. C., Wang, J. C., and Liu, L. F. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin. Mol. Cell. Biol., 6:985-992, 1986.
33. Moseley, P. L., York, S. J., and York, J. Bleomycin induces the HSP-70 heat shock promoter in cultured cells. Am. J. Resp. Cell. Mol. Biol., 1: 89-93, 1989.
34. Shen, J., Hughes, C., Chao, C., Cai, J., Bartels, C., Gessner, T., and Subjeck, J. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc. Natl. Acad. Sci. USA, 84:3278-3282,1987.
35. Hughes, C. S., Shen, J. W., and Subjeck, J. R. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res., 49:4452-4454, 1989.
36. Crete, P., and Landry, J. Induction of HSP27 phosphorylation and thermoresistance in Chinese hamster cells by arsenite, cycloheximide, A23187 and EGTA. Radiat. Res., 121: 320-327,1990.
37. Huot, J., Lambert, H., Roy, G., and Landry, J. Atypical multidrug resistance conferred by expression of the human HSP27 heat shock gene in Chinese hamster cells. Eur. J. Pharmacol., 183: 1632-1633,1990.
38. Chretien, P., and Landry, J. Enhanced constitutive expression of the 27-kDa heat shock proteins in heat-resistant variants from Chinese hamster cells. J. Cell. Physiol., 137: 157-166, 1988.
39. Landry, J., Chretien, P., Lambert, H., Hickey, E., and Weber, L. A. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J. Cell Biol., 109: 7-15, 1989.
40. Pouyssegur, J., Franchi, A., Salomon, J. C., and Sylvestre, P. Isolation of a Chinese hamster fibroblast mutant defective in hexose transport and aerobic glycolysis: its use to dissect the malignant phenotype. Proc. Natl. Acad. Sci. USA, 77: 2698-2701, 1980.
41. Ling, V., and Thompson, L. H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell. Physiol., 83: 103-111,1974.
42. Hickey, E., Brandon, S. E., Potter, R., Stein, G., Stein, J., and Weber, L. A. Sequence and organization of genes encoding the human 27 kDa heat shock protein. Nucleic Acids Res., 14:4127-4145,1986.
43. Mulligan, R. C., and Berg, P. Selection for animal cells that express the E. coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA, 78: 2072-2076,1981.
44. Inaba, M., Kobayashi, H., Sakurai, Y., and Johnson, R. K. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res., 39: 2200-2203,1982.
45. Politi, P. M., and Sinha, B. K. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Mol. Pharmacol., 35: 271-278, 1989.
46. Towbin, H. T., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76:4350-4354,1979.
47. Haber, M., Norris, M. B., Kavallaris, M., Bell, O. R., Davey, R. A., White, L., and Stewart, B. W. Atypical multidrug resistance in a therapy-induced drug resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res., 49: 5281-5287, 1989.
48. Ross, D. D., Thompson, B. W., Ordonez, J. V., and Joneckis, C. Improvement of flow cytometry detection of multidrug resistant cells by volume normalization of intracellular daunorubicin content. Cytometry, 10: 185-191, 1989.
49. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455: 152-162, 1976.
50. Danks, M. K., Yalowich, J. C., and Beck, W. T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res., 47: 1297-1301, 1987.
51. Abdella, B. R. J., and Fisher, J. A. A chemical perspective on the anthracyclin antitumor antibiotics. Environ. Health Perspect., 64:3-18, 1985.
52. Lown, J. W. Molecular mechanism of action of anticancer agents involving free radical intermediates. Adv. Free Radical Biol. Med., 1: 225-264,1985.
53. Doroshow, J. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen scavengers and iron chelating agents. Biochem. Biophys. Res. Commun., 135:330-335,1986.
54. Sinha, B. K., Katki, A. G., Batist, G., Cowan, K. H., and Myers, C. E. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry, 26: 3776-3781,1987.
55. Mimnaugh, E. G., Dusre, L., Atwell, J., and Myers, C. E. Differential oxygen radical susceptibility of adriamycin-sensitive and resistant MCF-7 human breast tumor cells. Cancer Res., 49: 8-15, 1989.
56. Freeman, M. L., Scidmore, N. C., Malcolm, A. W., and Meredith, M. J. Diamide exposure, thermal resistance, and synthesis of stress (heat shock) proteins. Biochem. Pharmacol., 36:21-29, 1987.
57. Arrigo, A. P., Suhan, J. P., and Welch, W. J. Dynamic changes in the structure and intracellular locale of the mammalian low-molecular-weight heat shock protein. Mol. Cell. Biol., 8:5059-5071,1988.
58. Landry, J., Chretien, P., Laszlo, A., and Lambert, H. Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cells. J. Cell. Physiol., 147:93-101,1991.
59. Shen, J. W., Subjeck, J. R., Lock, R. B., and Ross, W. E. Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response. Mol. Cell. Biol., 9:3284-3291, 1989.
60. Arrigo, A. P. Tumor necrosis factor induces the rapid phosphorylation of the mammalian heat shock protein hsp28. Mol. Cell. Biol., 10:1276-1280,1990.
61. Darbon, J. M., Issandou, M., Toumier, J. F., and Bayard, F. The respective 27 kDa and 28 kDa protein kinase C substrates in vascular endothelial and MCF-7 cells are most probably heat shock proteins. Biochem. Biophys. Res. Commun., 168: 527-536, 1990.
62. Dollbaum, C., Creasey, A. A., Dairkee, S. H., Hiller, A. J., Rudolph, A. R., Lin, L., Vitt, C., and Smith, H. S. Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc. Natl. Acad. Sci. USA, 85:4740-4744, 1988.
63. Ferguson, P. J., and Cheng, Y. C. Transient protection of cultured human cells against antitumor agents by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res., 47:433-441, 1987.
64. Fine, R. L., Patel, J., and Chabner, B. A. Phorbol esters induce multidrug resistance in human breast cells. Proc. Natl. Acad. Sci. USA, 85: 582-586, 1988.
65. Willingham, M. C., Cornwell, M. M., Cardarelli, C. O., Gottesman, M. M., and Pastan, I. Single cell analysis of daunomycin uptake and efflux in multidrug resistant and -sensitive KB cells: Effects of verapamil and other drugs. Cancer Res., 46: 5941-5946, 1986.
66. Klohs, W. D., and Steinkampf, R. W. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol. Pharmacol., 34: 180-185, 1988.
67. Hindenburg, A. A., Gervasoni, J. E., Jr., Krishna, S., Stewart, V. J., Rosado, M., Lutzky, J., Bhalla, K., Baker, M. A., and Taub, R. N. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res., 49:4607-4614, 1989.
68. Fuqua, S. A., Blum-Salingaros, M., and McGuire, W. L. Induction of the estrogen-regulated “24K” protein by heat shock. Cancer Res., 49: 4126-4129, 1989.
69. Ciocca, D. R., Puy, L. A., and Fasoli, L. C. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mt 24,000 protein in patient with carcinomas of the endometrium and cervix. Cancer Res., 49: 4298-4304, 1989.
70. Adams, D. J., and McGuire, W. L. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Afr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors. Cancer Res., 45: 2445-2449, 1985.
71. Puy, L. A., Lo Castro, G., Olcese, J. E., Lotfi, H. O., Brandi, H. R., and Ciocca, D. R. Analysis of a 24-kilodalton (KD) protein in the human uterine cervix during abnormal growth. Cancer (Phila.), 64: 1067-1073, 1989.
72. Thor, A., Benz, C., Moore II, D., Golman, E., Edgerton, S., Landry, J., Schwartz, L., Hickey, H., and Weber, L. Stress response protein (srp-27) determination in primary human breast carcinomas: clinico-histologic correlations and prognostic significance. J. Natl. Cancer Inst., 83: 170-177, 1991.
73. Chamness, G. C., Ruiz, A., Fulcher, L., Clark, G., Fuqua, S., and McGuire, W. Estrogen-inducible heat shock protein hsp27 predicts recurrence in nodenegative breast cancer. Proc. Am. Assoc. Cancer Res., 30:252,1989.
74. Tandon, A. K., Clark, G. M., Chamness, G. C., Fuqua, S. A. W., Welch, W. J., Riehl, R. M., and McGuire, W. L. Heat shock stress response proteins: biological and clinical significance in breast cancer. Proc. Am. Soc. Clin. Oncol., 9: 84, 1990.